The relationships that have come out of our local sponsors and partners over the years have been invaluable. True partnerships. Our Community Sponsors are critical in helping us make a dent in and impact rare pediatric cancer research. We simply cannot continue to grow our impact without this support.
ISF is committed to improving rare pediatric cancer treatment options in an effort to increase survival rates of kids with cancer so they can live their dreams. Our partnership with Levine Children’s funds the ISF Rare and Solid Tumor Program. This program oversees care for all solid tumors, rare tumors, MIBG therapy, and all related clinical and scientific research at the hospital.
There are so many ways your business can join us in 2023 to make an impact. And this isn’t a set list, email our Director of Sponsorships & Partnerships, Karen, and let’s get creative! We are always up for out of the box ideas…
- Sponsor an ISF Event
- Donate Auction Items
- Host an ‘ISF Day’ With a % Give Back
- Make a Donation & Company Matching
- Donate In-Kind Items for ISF Events
- Sign Your Team Up to Volunteer With ISF
- Register Your Team for ISF’s Annual 5K/10K
Join other amazing businesses helping us implement successful ISF events throughout the year. With each event and each year, we continue to raise the bar and hope you will join us. Contact Karen Murphy to discuss how your business can get involved.
A Sustaining Sponsor is an annual sponsor of the Isabella Santos Foundation and extremely integral in bringing lasting change to pediatric cancer research. As an ISF Sustaining Sponsor, your business will have the opportunity to align your company through positive community awareness with many marketing benefits and events. (Sustaining Sponsorships are limited.)
Our ISF Event Sponsorships are a great way to increase brand awareness and engage with people in the community all while providing an impact on pediatric cancer. Available throughout the year at various levels.
2023 Proposed Event Sponsorship Opportunity Details Coming Soon.